caplacizumab
sanofi
['caplac']
the two debaters at #ash22 on the role of caplacizumab in #ttp were asked on how many patients with ttp in their hospitals get caplacizumab. the answers were 80% and 0%.
Professor of Haemostasis and Thrombosis in Sheffield, UK. I tweet about thrombosis, hemophilia, COVID-19, medicine & NHS. Opinions are my own.